
Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
January 5th, 2023
Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
January 5th, 2023
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Will your cat need a COVID-19 vaccine?
January 28th, 2021
Inside The Two Biotech Companies Working Together On A Covid-19 Vaccine For Cats
January 6th, 2021
APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
Veterinary COVID-19 Vaccine Clinical Trial
September 16th, 2020